Human immunodeficiency virus infection and macrophage cholesterol metabolism
- 1 November 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 80 (5), 1044-1051
- https://doi.org/10.1189/jlb.0206113
Abstract
Macrophages play a central role in the pathogenesis of atherosclerosis and are also a host for a number of viruses, most importantly, HIV. Many viruses, including HIV, require cholesterol for their replication and as a structural element. Cholesterol also plays a pivotal role in innate antiviral immune responses. Although impairing innate immune response by increasing cell cholesterol content may be a deliberate strategy used by a pathogen to improve its infectivity, enhancing the risk of atherosclerosis is likely a byproduct. Consistent association between HIV infection and elevated risk of atherosclerosis suggested a connection between virus-induced changes in cholesterol metabolism and atherogenesis, but the mechanisms of such connection have not been identified. We describe in this review various mechanisms enabling viruses to exploit macrophage pathways of cholesterol metabolism, thus diverting cholesterol for a purpose of increasing viral replication and/or for altering innate immune responses. To alter the cellular cholesterol content, viruses “hijack” the pathways responsible for maintaining intracellular cholesterol metabolism. The damage to these pathways by viral infection may result in the inability of macrophages to control cholesterol accumulation and may lead to formation of foam cells, a characteristic feature of atherosclerosis. Further elucidation of the mechanisms connecting viral infection and macrophage cholesterol metabolism may be fruitful for developing approaches to treatment of atherosclerosis and viral diseases.Keywords
This publication has 93 references indexed in Scilit:
- Consequences of cellular cholesterol accumulation: basic concepts and physiological implicationsJCI Insight, 2002
- Cholesterol in health and diseaseJCI Insight, 2002
- Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissuesProceedings of the National Academy of Sciences, 2002
- Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Tangier disease and ABCA1Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- AtherosclerosisNature, 2000
- Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceJCI Insight, 2000
- Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen speciesJCI Insight, 2000
- A proteolytic pathway that controls the cholesterol content of membranes, cells, and bloodProceedings of the National Academy of Sciences, 1999
- Lipoprotein Trafficking in Vascular CellsJournal of Biological Chemistry, 1997